Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Category
Equity - Leveraged / Inverse
Sponsor
Defiance ETFs
Fund Family
Index
-
Index Weighting
Active/Passive
Expense
1.32%
Inverse/Leveraged
IPO
Aug 08, 2024
Asset Type
Equities (Stocks)
ETF Type
Bond Type
Average Maturity
Commodity Type
Quant Type
ESG Type
Dividend Type
Structure Type
Growth/Value
Market Cap
Option/Short
Yes / Yes
Tags
Tags
Tags
Tags
Tags
-
Tags
-
Tags
-
Sector/Theme
Region
SMA20
-5.14%
SMA50
-1.14%
SMA200
13.71%
Return% 1Y
73.39%
Return% 3Y
-
Return% 5Y
-
Return% 10Y
Return% SI
Flows% 1M
-33.61%
Flows% 3M
-49.27%
Flows% YTD
16.89%
Flows% 1Y
Flows% 3Y
Flows% 5Y
Trades
Total Holdings
9
AUM
45.81M
NAV/sh
52W High
29.95 -15.56%
52W Low
9.60 163.44%
Volatility
4.67% 5.66%
ATR (14)
1.53
RSI (14)
45.96
Beta
0.60
Rel Volume
0.52
Avg Volume
478.70K
Volume
12,350
Perf Week
-7.19%
Perf Month
-10.35%
Perf Quarter
37.07%
Perf Half Y
8.49%
Perf YTD
-0.78%
Perf Year
71.23%
Perf 3Y
-
Perf 5Y
-
Perf 10Y
-
Prev Close
24.96
Price
25.29
Change
1.32%
Apr-22-25 08:07AM
Defiance Daily Target 2X Long LLY ETF seeks daily leveraged investment results of two times (200%) the daily percentage change in the share price of Eli Lilly and Company. The fund will enter into one or more swap agreements with financial institutions for a specified period, which may range from one day to longer than a year. The advisor has adopted a policy to have at least 80% exposure to financial instruments with economic characteristics that should perform 2X the daily performance of the underlying security's shares. The fund is non-diversified.